Page last updated: 2024-08-24

trovafloxacin and Cardiovascular Diseases

trovafloxacin has been researched along with Cardiovascular Diseases in 1 studies

Research

Studies (1)

Timeframe	Studies, this research(%)	All Research%
pre-1990	0 (0.00)	18.7374
1990's	0 (0.00)	18.2507
2000's	1 (100.00)	29.6817
2010's	0 (0.00)	24.3611
2020's	0 (0.00)	2.80

Authors

Authors	Studies
Boada, C; Boada, JN; Fernández, E; García, M; García-Sáiz, M; Gómez, E	1

Other Studies

1 other study(ies) available for trovafloxacin and Cardiovascular Diseases

Article	Year
Net efficacy adjusted for risk (NEAR): a simple procedure for measuring risk:benefit balance. PloS one, 2008, Volume: 3, Issue:10 Topics: Anti-Bacterial Agents; Anti-Inflammatory Agents; Cardiovascular Diseases; Drug-Related Side Effects and Adverse Reactions; Fluoroquinolones; Gemifloxacin; Humans; Hydroxymethylglutaryl-CoA Reductase Inhibitors; Models, Theoretical; Naphthyridines; Pneumonia; Preventive Medicine; Randomized Controlled Trials as Topic; Risk Assessment; Treatment Outcome	2008

Article

Year

Net efficacy adjusted for risk (NEAR): a simple procedure for measuring risk:benefit balance.

PloS one, 2008, Volume: 3, Issue:10

Topics: Anti-Bacterial Agents; Anti-Inflammatory Agents; Cardiovascular Diseases; Drug-Related Side Effects and Adverse Reactions; Fluoroquinolones; Gemifloxacin; Humans; Hydroxymethylglutaryl-CoA Reductase Inhibitors; Models, Theoretical; Naphthyridines; Pneumonia; Preventive Medicine; Randomized Controlled Trials as Topic; Risk Assessment; Treatment Outcome

2008